Table IV.
Variable | HR | 95% CI | P |
---|---|---|---|
Age, years | |||
<63 | 1.0 (Ref) | ||
63–70 | 1.3 | 1.2–1.5 | <.001 |
71–77 | 1.9 | 1.7–2.1 | <.001 |
≥78 | 3.5 | 3.2–3.9 | <.001 |
Male | 1.1 | 1.0–1.2 | <.001 |
Smoking | |||
Never | 1.0 (Ref) | ||
Former | 1 | 0.9–1.1 | .303 |
Current | 1.2 | 1.1–1.3 | <.001 |
Diabetes | |||
None | 1.0 (Ref) | ||
Diet | 1.3 | 1.1–1.5 | <.001 |
Oral medication | 1.2 | 1.1–1.3 | <.001 |
Insulin | 1.4 | 1.3–1.6 | <.001 |
CAD | |||
None | 1.0 (Ref) | ||
Prior MI | 1.2 | 1.1–1.3 | <.001 |
Stable angina | 1.1 | 0.9–1.2 | .096 |
Unstable angina/recent MI | 1.1 | 0.9–1.4 | .306 |
CHF | |||
None | 1.0 (Ref) | ||
Asymptomatic | 1.7 | 1.5–1.9 | <.001 |
Mild/moderate | 1.9 | 1.7–2.1 | <.001 |
Severe | 2.4 | 1.9–2.9 | <.001 |
COPD | |||
None | 1.0 (Ref) | ||
Not treated | 1.2 | 1.1–1.4 | .011 |
On medication | 1.5 | 1.4–1.6 | <.001 |
On oxygen | 2.2 | 1.9–2.5 | <.001 |
GFR, mL/min/1.73 m2 | |||
>60 | 1.0 (Ref) | ||
40–59 | 1.2 | 1.2–1.3 | <.001 |
30–39 | 1.6 | 1.5–1.8 | <.001 |
<30 | 2.7 | 2.4–3.0 | <.001 |
Missing | 2.9 | 2.6–3.3 | <.001 |
Living status | 2.1 | 1.8–2.4 | <.001 |
Prior bypass surgery | 1.2 | 1.1–1.3 | <.001 |
Prior major amputation | 1.3 | 1.2–1.4 | <.001 |
Procedure | |||
CAS | 1.0 (Ref) | ||
CEA | 0.7 | 0.6–0.8 | <.001 |
oAAA | 0.8 | 0.6–0.9 | .017 |
EVAR | 0.9 | 0.7–1.0 | .06 |
Suprainguinal bypass | 1.2 | 1.0–1.5 | .057 |
Infrainguinal bypass | 1.2 | 1.0–1.4 | .03 |
PVI | 1.1 | 1.0–1.3 | .128 |
TEVAR | 1.3 | 0.9–2.0 | .124 |
Medication | |||
None | 1.0 (Ref) | ||
Aspirin | 0.8 | 0.7–0.9 | <.001 |
Statin | 0.8 | 0.7–0.9 | .011 |
Both | 0.6 | 0.5–0.7 | <.001 |
VQI | |||
<3 years | 1.0 (Ref) | ||
≥3 years | 1 | 0.9–1.1 | .684 |
CAS, Carotid artery stenting; CEA, carotid endarterectomy; CHF, congestive heart failure; CI, confidence interval; COPD, chronic obstructive pulmonary disease; EVAR, endovascular abdominal aortic aneurysm repair; GFR, glomerular filtration rate; HR, hazard ratio; MI, myocardial infarction; oAAA, open abdominal aortic aneurysm repair; PVI, peripheral vascular intervention; TEVAR, thoracic endovascular aortic repair; VQI, Vascular Quality Initiative.